NewGenIvf Group Limited (NIVF) Stock Score, Valuation & Financial Research
NewGenIvf Group Limited is in the Healthcare sector and Medical - Care Facilities industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 59/100.
Quick answer for NIVF
NewGenIvf Group Limited currently has a Wall Street Score of 59/100. The stored market price is $0.72. Its financial score is 0/100. Its valuation score is 100/100. The latest WSS change is -1.6 points. These figures are a research snapshot, not a buy or sell recommendation.
What NewGenIvf Group Limited does
Operating out of its headquarters in Bangkok, Thailand, NewGenIvf Group Limited specializes in delivering assisted reproductive services. The firm is committed to fulfilling the desire for family through a variety of fertility treatments. Its extensive service portfolio includes conventional in-vitro fertilization (IVF), egg donation, and surrogacy, all complemented by comprehensive ancillary care.
NIVF financial snapshot
- Wall Street Score:
- 59/100
- Current price:
- $0.72
- Market capitalization:
- $45K
- Revenue:
- $5.5M
- Net income:
- $9.0M
- Free cash flow:
- $-16.7M
- Cash:
- $759K
- Total debt:
- $4.9M
- EPS:
- 86.91
- P/E ratio:
- 0.0x
- Financial score:
- 0/100
- Valuation score:
- 100/100
- Revenue score:
- 70/100
What stands out
- Reported year-over-year revenue growth is +0.2%.
- Free cash flow is $-16.7M, showing cash burn in the current stored period.
- The balance sheet shows $759K of cash versus $4.9M of total debt, so leverage deserves attention.
- The latest Wall Street Score change is -1.6 points: NIVF decreased 1.6 points because some fundamentals weakened.
- The current research record carries a high debt stress warning, which should be reviewed alongside the score.
Questions worth answering for NIVF
These questions are derived from the company's current stored financial and score data so the page adds company-specific research context instead of treating the headline score as a stand-alone conclusion.
- Can NIVF maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- How long can NIVF fund negative free cash flow using its current cash position before it may need more debt or new shares?
- Is NIVF's debt load manageable relative to cash generation, interest costs and upcoming maturities?
- Is NIVF's valuation discount tied to a temporary concern or to a longer-term business risk?
- What does the current high debt stress warning mean for the reliability or interpretation of NIVF's score?
What the numbers mean
Its current valuation score is 100/100, which Wall Street Score classifies as strong within the model's valuation framework.
The financial score is 0/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-19.
Research-input completeness: 100% of the scoring inputs required for this public page are currently available.
How to research NIVF
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.